Women in Electrophysiology

While I was chatting with a few fellows in our hospital hallway, I met one of the fellows who was very interested in electrophysiology (EP). We had a very interesting chat about her application and future career forward. In this blog, I summarize my chat with Jasneet Devgun, an aspiring electrophysiologist. Question: Hi Jasneet, great … Read more

Sleep and Ideal Cardiovascular Health

During the AHA’s Scientific Session 2021, heart health, defined by the Life’s Simple 7 metric, was often woven into health equity conversations. Empirical evidence consistently supports AHA’s recognition of these seven risk factors that people can avoid or improve on through lifestyle changes to help achieve ideal cardiovascular health. Regardless of how challenging this goal … Read more

The tension between generalizability and inclusivity in population research

As I have continued my journey in epidemiologic research, one of my primary aims is to illuminate health disparities within my projects. Currently located in New York City, identifying diverse populations is hardly an issue. However, I have thought more about populations around the United States as I apply to PhD programs and consider the … Read more

Electronic Cigarette Customization Matters.

Electronic nicotine delivery systems (ENDS) are increasingly popular as an alternative to standard ‘combustion’ cigarettes.  ENDS come in a large variety of forms and offer adulterant choices that enhance the user’s experience, such as flavors, humectants, and nicotine in different concentrations. There is a common perception that vaping is a safer alternative to traditional tobacco … Read more

Zooming In: The Impact of the COVID-19 Pandemic on PhD Interviews

The COVID-19 pandemic has brought significant changes to multiple layers of academia, including the biological and biomedical sciences PhD admissions process in the United States. Typically, prospective applicants are selected to interview in-person at the destination campus not only as a part of the evaluation process, but also as an opportunity for the applicants to … Read more

A Scientific Statement from the American Heart Association on the Management of Cardiovascular Risk Factors for Adults with Type 2 Diabetes

The prevalence of diabetes is increasing at an alarming rate, with more than 34 million Americans suffering from diabetes1. Patients with type 2 diabetes make up 90% to 95% of total diabetes cases1. Cardiovascular diseases (CVD) are the principal cause of death and disability in type 1 and type 2 diabetes patients2. American Heart Association … Read more

The darkness before the dawn–Long COVID is lurking around

As we are starting to live with the facts that COVID-19 is not leaving us any time soon, sense of danger and urgency start to fade away. More than two years have passed, we have made great strides in combating the pandemics. With advanced technologies, vaccine and antiviral drug developments provide us potential means out … Read more

Moyamoya Disease

Moyamoya disease is a progressive cerebrovascular disorder that often begins during childhood. Patients with Moyamoya disease have injuries in their blood vessels at the base of the brain. The term ‘moyamoya’ comes from Japanese and means ‘puff of smoke’, which describes the appearance of abnormal blood vessels. Symptoms of Moyamoya disease include acute strokes, transient … Read more

Elevated Lipoprotein A, are we ready to intervene?

Lipid abnormalities can be classified into four clinical groups:1) elevated triglycerides, 2) low high-density lipoprotein cholesterol (HDL-C),3) elevated low-density lipoprotein cholesterol (LDL-C), and 4) elevated lipoprotein A.  Lipoprotein A disorder has been the least lipid abnormality studied from a clinical standpoint. Although many mendelian and genome-wide association studies have shown an association between elevated lipoprotein … Read more